Opinion
Video
Optimizing Multidisciplinary Care Approaches for the Future of SMA Management
Author(s):
Panelists discuss how communication between clinicians, patients, and payers could improve equitable access to spinal muscular atrophy (SMA) treatments, while acknowledging the complex value assessment of high-cost therapies vs improved quality and length of life.
Clinical Brief: Stakeholder Collaboration for Equitable SMA Treatment Access
Main Discussion Topics
- Need for collaboration between clinicians, payers, and patient advocates
- Psychosocial impact of performance-based treatment authorization
- Potential approaches to facilitate more equitable treatment access
- Communication strategies to address coverage uncertainties
Key Points for Physicians
- Direct communication between clinicians and payers can improve mutual understanding of treatment value.
- Performance-based authorization creates significant anxiety for patients during assessments.
- State Medicaid engagement has proven beneficial in developing reasonable policies for patients with SMA.
- Multiple stakeholder perspectives are needed to develop balanced approaches to treatment access.
Notable Insights
The panel described the psychological burden on patients when assessments determine treatment continuation, likening it to "going to the Olympics every time" with the pressure to perform well enough to maintain therapy access.
Clinical Significance
Collaborative approaches involving clinicians, payers, and patient advocates can lead to more equitable and sustainable access to SMA treatments while acknowledging resource limitations and the need for evidence-based decision-making.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
